VISGENX
Visgenx develops therapeutics to protect against the loss of sight from retinal disorders. Its programs are based on increasing the expression of a gene known as ELOVL2 which may regulate aging in cells critical for vision.
VISGENX
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
2018-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.visgenx.com
Total Employee:
1+
Status:
Active
Total Funding:
5.75 M USD
Similar Organizations
Cognition Therapeutics
Cognition Therapeutics develops new therapeutics to treat patients suffering from Alzheimer’s disease and other neurodegenerative disorders.
NFlection Therapeutics
NFlection focuses on the development of novel therapies to address the needs of patients.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Tilden Bio
Tilden Bio develops photosynthetic bioproducts including natural plant essential oils, cannabinoids, and biopharmaceutical proteins.
Valitor
Valitor has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacological properties..
Zavante Therapeutics
Zavante focuses on developing novel therapies to improve the outcomes of hospitalized patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
Tech Coast Angels
Tech Coast Angels investment in Convertible Note - Visgenx
Official Site Inspections
http://www.visgenx.com
- Host name: 159.178.193.35.bc.googleusercontent.com
- IP address: 35.193.178.159
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
